Stay updated on Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial

Sign up to get notified when there's something new on the Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Footer revision updated to v3.4.3; the page content remains unchanged.
    Difference
    0.0%
    Check dated 2026-03-11T16:57:28.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new site revision label 'Revision: v3.4.2' is added, and previous notices about government funding lapses and NIH operating status are removed.
    Difference
    0.3%
    Check dated 2026-02-11T09:22:27.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide funding notice about government appropriations and updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T05:33:48.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle, introduced a new 'Last Update Submitted that Met QC Criteria' field, and updated the revision label to v3.4.0, with minor wording changes to QC/FEAR Act data.
    Difference
    0.2%
    Check dated 2026-01-28T03:58:40.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page adds Revision: v3.3.4 and removes Revision: v3.3.3 as part of a metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:28:39.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A consolidated 'Locations' section listing multiple state sites (Alabama, California, Florida, Georgia, Illinois, Louisiana, Missouri, New York, North Carolina, Texas, Washington) was added, replacing the previous state-specific headings; the 'HHS Vulnerability Disclosure' link was removed and the page revision updated to v3.3.3.
    Difference
    1.0%
    Check dated 2025-12-23T12:43:10.000Z thumbnail image

Stay in the know with updates to Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial page.